SCHEMBL13008243

SCHEMBL13008243

c1ccc2c(c1)Cc1ccccc1N2c1ccc2c(-c3cccc4ccccc34)c3cc(N4c5ccccc5Cc5ccccc54)ccc3c(-c3ccc4ccccc4c3)c2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 1/20 0.35
PIM1 P11309 2/20 0.34
POLB P06746 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
HPGD P15428 1/20 0.32
CYP2C19 P33261 1/20 0.32
HDAC4 P56524 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
PRKDC P78527 1/20 0.31
AKT1 P31749 1/20 0.31
PDE6D O43924 1/20 0.30
CTDSP1 Q9GZU7 1/20 0.30
HSP90AA1 P07900 1/20 0.30
SOS1 Q07889 1/20 0.30
CYP1A1 P04798 1/20 0.30
CYP1B1 Q16678 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13008230 0.97 MET (0.34) METPIM1POLBALDH1A1LMNA
SCHEMBL13008239 0.96 PIM1 (0.35) METPIM1POLBALDH1A1LMNA
SCHEMBL13427043 0.96 MET (0.34) METPIM1POLBALDH1A1LMNA
SCHEMBL13009130 0.95 PDE6D (0.36) METPIM1POLBHPGDPDE6D
SCHEMBL13427037 0.94 MET (0.39) METPIM1POLBALDH1A1LMNA
SCHEMBL13427001 0.94 MET (0.37) METPIM1POLBALDH1A1LMNA
SCHEMBL13426993 0.94 MET (0.39) METPIM1POLBALDH1A1LMNA
SCHEMBL13008450 0.93 CYP1A2 (0.36) METPIM1POLBALDH1A1LMNA
SCHEMBL13009236 0.92 HSP90AA1 (0.35) METALDH1A1LMNACYP1A2CYP2C9
SCHEMBL13427007 0.91 MET (0.39) METALDH1A1LMNACYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2256176-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-12-01 EP disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
EP-2141214-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A MET 3253/4885PIM1 3158/4885POLB 913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.